Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label outpatient extension study of Staccato alprazolam for prolonged stereotypical seizures
jRCT2061210061Recruiting
- Sponsor
- UCB
- Start
- Dec 2021
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of alprazolam in epilepsy, sponsored by UCB. Primary endpoints: Frequency of treatment-emergent adverse events, Frequency of treatment-emergent adverse events leading to withdrawal and 1 more. Started Dec 2021; status: recruiting.
02
Drugs
alprazolam
03
Conditions
epilepsy
Beyond the preview
Go deeper on jRCT2061210061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2061210061.